Share Split / Sub-Division.( ECOBIOTICS ) 6 for 1. not sure this is a good or bad thing long term. probable makes nil difference, but my vote will be against the proposal. phase 1/2 for human trial mid 2012 is good IMO with some interest from magor pharm coy's already is encouraging. i take it the EBC-46 drug has been successfully obtained from the plantation material after some prior hicups, that can only be good. slow in getting the minor use to the vet market probable should have been expected but dissappointing none the less, the whole process is long term stuff i suppose
